top of page
Knowledge Hub


Xcelom Participates in Key Thalassemia Conference in Bangkok, Thailand
Through this event, Xcelom strengthened regional engagement and showcased the potential of long-read sequencing in supporting thalassemia screening and diagnosis. Xcelom was pleased to partner with DKSH Technology Thailand and PacBio to participate in the national conference “Thalassemia-Free Generations Through Advanced Laboratory Technologies”, held in Bangkok, Thailand, from July 22–24, 2026. Partner booth of DKSH Technology Thailand and PacBio at the Thalassemia-Free Gene
PacBio PRISM 2026 in Fukuoka
We have returned from PacBio PRISM 2026 in Fukuoka, where our team joined Dr. Aiping Mao, Head of R&D at Berry Genomics, and Dr Bo Wang, leader from Haorui Genomics, for an inspiring event with leaders, partners, and innovators from across the PacBio ecosystem.
Building a Targeted LRS Panel for Newborn CAH Screening
How Long-Read Sequencing resolves the CYP21A2-TNXB highly homologous pseudogene challenge and enhances first-tier screening. Introduction: The Evolution of Newborn Screening Compared to traditional biochemical assays, Genetic Newborn Screening (NBS) offers a distinct advantage: clearer results, reduced unnecessary follow-up, and the ability to detect conditions that lack early-stage biochemical markers. Thanks to advancements in sequencing technology, laboratories can now scr
bottom of page
